AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On June 2, 2025,
(PFE) experienced a significant drop in trading volume, with a total of $712 million in shares traded, marking a 46.45% decrease from the previous day. This placed Pfizer at the 105th position in terms of trading volume for the day. The stock price of Pfizer also decreased by 0.13%.Pfizer has faced challenges over the past three years, with revenue and earnings declining, which has also impacted the company's share price. The company's stock has been under pressure due to various factors, including the expiration of patents on key drugs and increased competition in the pharmaceutical market.
Recently, Pfizer revealed the Phase 3 results for Vepdegestrant in advanced breast cancer, which could potentially impact the company's future prospects. Additionally, Pfizer and Arvinas are planning to seek FDA approval for a jointly developed drug, which could provide a boost to the company's pipeline and investor sentiment.
Investors are also keeping an eye on upcoming events that could significantly impact Pfizer's stock price, such as FDA announcements and earnings reports. These events could provide clarity on the company's future performance and help investors make informed decisions.
Hunt down the stocks with explosive trading volume.

Dec.05 2025

Dec.05 2025

Dec.05 2025

Dec.05 2025

Dec.05 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet